Showing results (161-170 of 722) with videos related to
Sort By:
Pageof 73
The Lancet. Haematology|February 1, 2024
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trialElias K Mai, Hartmut Goldschmid, Kaya Miah, et al.The Lancet. Haematology|February 1, 2024
Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort studyPauline Hägele, Paulina Staus, Raphael Scheible, et al.The Lancet. Haematology|March 22, 2026
Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trialEmel Aygören-Pürsün, Marcin Stobiecki, Anna Valerieva, et al.The Lancet. Haematology|May 2, 2024
Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statementMarcin W Wlodarski, Adrianna Vlachos, Jason E Farrar, et al.The Lancet. Haematology|April 7, 2024
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trialMatthias Stelljes, Jan Moritz Middeke, Gesine Bug, et al.The Lancet. Haematology|April 4, 2026
Implications of changes in WHO haemoglobin elevation adjustment guidelines on global, regional, and national anaemia burden, 1990-2023: a population-based modelling studyCorey J Teply, William M Gardner, Taylor S Noyes, et al.The Lancet. Haematology|May 2, 2026
Very early [18F]FDG-PET-guided targeted therapy in untreated advanced-stage classic Hodgkin lymphoma (EORTC-1537-COBRA): primary results of a single-arm, multicentre, phase 2 trialMartin Hutchings, Arjan Diepstra, Anna Sureda Balari, et al.The Lancet. Haematology|July 30, 2021
Physiologically based serum ferritin thresholds for iron deficiency in children and non-pregnant women: a US National Health and Nutrition Examination Surveys (NHANES) serial cross-sectional studyZuguo Mei, O Yaw Addo, Maria Elena Jefferds, et al.The Lancet. Haematology|September 2, 2026
High time for risk-adapted treatment in mantle cell lymphomaIngrid Glimelius, Anna Nikkarinen, Leo Meriranta, et al.Pageof 73